Sahacogen (Chonburi) Public Company Limited (SCG.BK)
THB 3.5
(2.34%)
THB 3.5
(2.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5.04 Billion | 5.74 Billion | 4.22 Billion | 3.97 Billion | 4.31 Billion | 4.19 Billion |
| Cost of Revenue | 4.8 Billion | 5.8 Billion | 3.96 Billion | 3.6 Billion | 3.88 Billion | 3.65 Billion |
| Gross Profit | 238.87 Million | -59.4 Million | 259.19 Million | 367.33 Million | 438.55 Million | 541.99 Million |
| Operating Expenses | 296.09 Million | 151.36 Million | 182.37 Million | 127.01 Million | 142.89 Million | 152.14 Million |
| Selling, General and Administrative Expenses | 358.85 Million | 151.36 Million | 182.37 Million | 127.01 Million | 142.89 Million | 152.14 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -62.75 Million | 19.09 Million | 12.34 Million | 7.28 Million | 5.2 Million | 8.88 Million |
| Cost and Expenses | 5.1 Billion | 5.95 Billion | 4.14 Billion | 3.73 Billion | 4.02 Billion | 3.8 Billion |
| Operating Income | 253.39 Million | -189.69 Million | 87.27 Million | 247.85 Million | 302.66 Million | 389.85 Million |
| Interest Expense | 135.96 Million | 107.58 Million | 108.14 Million | 128.93 Million | 143.11 Million | 168.27 Million |
| Income Tax Expense | 36.44 Million | -57.43 Million | -13.39 Million | -201.5 Thousand | 18.8 Million | 6.48 Million |
| Earnings before Tax | 130.48 Million | -286.61 Million | 93.48 Million | 117 Million | 156.79 Million | 231.37 Million |
| Net Income | 92.27 Million | -229.17 Million | 101.63 Million | 106.15 Million | 139.31 Million | 215.05 Million |
| Earnings Per Share Basic | 0.08 | -0.20 | 0.11 | 0.11 | 0.15 | 0.23 |
| Earnings Per Share Diluted | 0.08 | -0.20 | 0.11 | 0.11 | 0.15 | 0.23 |
| Weighted Average Shares Outstanding | 1.16 Billion | 1.16 Billion | 965.86 Million | 955 Million | 955 Million | 955 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.16 Billion | 1.16 Billion | 965.86 Million | 955 Million | 955 Million | 955 Million |
| Gross Margin | 0.05 | -0.01 | 0.06 | 0.09 | 0.10 | 0.13 |
| EBIT Margin | 0.16 | 0.07 | 0.16 | 0.21 | 0.18 | 0.22 |
| Profit Margin | 0.02 | -0.04 | 0.02 | 0.03 | 0.03 | 0.05 |
| EBITDA | 808.73 Million | 393.8 Million | 807.68 Million | 862.22 Million | 795.34 Million | 906.9 Million |
| Earnings Before Tax Margin | 0.05 | -0.03 | 0.02 | 0.06 | 0.07 | 0.09 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 875.37 Million | 1.11 Billion | 5.04 Billion | 1.1 Billion | 1.22 Billion | 1.3 Billion |
| Cost of Revenue | 805.27 Million | 1.09 Billion | 4.8 Billion | 1.06 Billion | 1.12 Billion | 1.22 Billion |
| Gross Profit | 70.09 Million | 22.87 Million | 238.87 Million | 32.1 Million | 95.13 Million | 70.47 Million |
| Operating Expenses | 48.34 Million | 39.86 Million | 296.09 Million | 169.88 Million | 51.29 Million | 55.35 Million |
| Selling, General and Administrative Expenses | 48.34 Million | 39.86 Million | - | 224.32 Million | 52.41 Million | 55.35 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -454 Thousand | - | - | - | - | 2.77 Million |
| Cost and Expenses | 853.62 Million | 1.13 Billion | 5.1 Billion | 1.23 Billion | 1.17 Billion | 1.28 Billion |
| Operating Income | 21.75 Million | -16.98 Million | 253.39 Million | 133.46 Million | 63.84 Million | 47.9 Million |
| Interest Expense | 45.02 Million | 32.83 Million | 135.96 Million | 33 Million | 35.35 Million | 34.23 Million |
| Income Tax Expense | -16.12 Million | -6.54 Million | 36.44 Million | 30.35 Million | 9.13 Million | 1.59 Million |
| Earnings before Tax | -10.63 Million | -45.86 Million | 130.48 Million | 99.6 Million | 31.72 Million | 17.01 Million |
| Net Income | 5.14 Million | -37.79 Million | 92.27 Million | 68.2 Million | 23.56 Million | 14.19 Million |
| Earnings Per Share Basic | 0.00 | -0.03 | - | 0.06 | 0.02 | 0.01 |
| Earnings Per Share Diluted | 0.00 | -0.03 | - | 0.06 | 0.02 | 0.01 |
| Weighted Average Shares Outstanding | 1.16 Billion | 1.16 Billion | 1.16 Billion | 1.16 Billion | 1.16 Billion | 1.16 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.16 Billion | 1.16 Billion | 1.16 Billion | 1.16 Billion | 1.16 Billion | 1.16 Billion |
| Gross Margin | 0.08 | 0.02 | 0.05 | 0.03 | 0.08 | 0.05 |
| EBIT Margin | 0.20 | 0.12 | - | 0.00 | 0.15 | 0.12 |
| Profit Margin | 0.01 | -0.03 | 0.02 | 0.06 | 0.02 | 0.01 |
| EBITDA | 172.64 Million | 136.83 Million | - | 4.01 Million | 184.22 Million | 154.75 Million |
| Earnings Before Tax Margin | 0.02 | -0.02 | 0.05 | 0.12 | 0.05 | 0.04 |
SWEC-A
INN
BIOCON
GCBC
NGIL
002410